financetom
Business
financetom
/
Business
/
Vestis Chairman Appointed as Interim CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vestis Chairman Appointed as Interim CEO
Mar 19, 2025 4:56 AM

07:34 AM EDT, 03/19/2025 (MT Newswires) -- Vestis ( VSTS ) said Wednesday it has named Phillip Holloman as Interim Executive Chairman, President and Chief Executive Officer, starting immediately.

Holloman has been serving as Chairman of the Vestis ( VSTS ) board of directors since 2023.

Holloman succeeds Kim Scott, who has left the company and its board of directors.

Vestis ( VSTS ) said the board has initiated a search for a permanent CEO

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spotify launches new basic streaming plan in US
Spotify launches new basic streaming plan in US
Jun 21, 2024
June 21 (Reuters) - Spotify ( SPOT ) introduced a new streaming plan for users in the United States on Friday, after raising prices for its premium plans earlier this month. The new basic plan will start at $10.99 per month for eligible users. It will have the streaming benefits of a premium plan, but no monthly audiobook listening time....
Why Gilead Sciences Stock Is Trading Higher Friday
Why Gilead Sciences Stock Is Trading Higher Friday
Jun 21, 2024
Gilead Sciences, Inc. ( GILD ) stock is moving higher Friday on continued strength following the company’s Phase 3 HIV data. What To Know: On Thursday before the market opened, Gilead announced efficacy data for its possible HIV prevention drug, Lenacapavir. The twice-yearly injectable indicated a 100% efficacy for HIV prevention in cisgender women. This data comes from the company’s...
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Jun 21, 2024
11:35 AM EDT, 06/21/2024 (MT Newswires) -- Nike's ( NKE ) commitment to faster and more meaningful product launches could drive sales turnaround in the second half of fiscal 2025, BofA Securities said in a note to clients. We have seen green shoots on the innovation front as three of its major retailers...are energized by its new products, BofA said,...
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Jun 21, 2024
11:38 AM EDT, 06/21/2024 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) received label expansion from the US Food and Drug Administration for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a best-case scenario and exceeding expectations, BofA Securities said Thursday in a report. Sarepta said late Thursday the agency approved the label expansion to include patients ages 4 and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved